Tetra Bio-Pharma (TSX VENTURE: $TBP.V) (OTCQB:
$TBPMF) to Benefit from Intellectual Properties Created within the #Cannabis
Health Research Chair from the University of New Brunswick
OTTAWA, ONTARIO - September 1, 2017
(Investorideas.com Newswire) Tetra Bio-Pharma Inc. ("Tetra" or the
"Company") (TSX VENTURE:TBP) (OTCQB:TBPMF), announced that it will
benefit from the intellectual property (IP) created within the cannabis health
research Chair (The Chair) from the University of New Brunswick (UNB). The
Corporation also provided a corporate update.
As part of the 5-year commitment from
Tetra and the New Brunswick Health Research Foundation (NBHRF) to The Chair,
Tetra will be offered the IP that will be created by The Chair. This important
clause in the collaboration with UNB and NBHRF will enable Tetra to obtain
licenses from the UNB based on the IP that will be generated from The Chair.
Read this news in full at http://www.investorideas.com/news/2017/marijuana/09012TSXVTBP-CannabisStock.asp
Marijuana /
Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp
Stocks Directory
Join our Group on Linkedin - Marijuana / Hemp
Stocks - News and Trends in Green Investing
Watch the 420 Cannabis Investor video
This
news is published on the Investorideas.com Newswire - a global digital news
source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of
third party sourced news, articles and equity research as well as creates
original content, including video, interviews and articles. Original content
created by investorideas is protected by copyright laws other than syndication
rights. Our site does not make recommendations for purchases or sale of stocks,
services or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investment involves risk
and possible loss of investment. This site is currently compensated for news
publication and distribution, social media and marketing, content creation and
more. Contact each company directly regarding content and press release
questions. Disclosure is posted for each compensated news release, content
published /created if required but otherwise the news was not compensated for
and was published for the sole interest of our readers and followers. More
disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional
info regarding BC Residents and global Investors: Effective September 15 2008 -
all BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
No comments:
Post a Comment